“Changes in Seizure Frequency and Antiepileptic Therapy during Pregnancy.”, N Engl J Med, vol. 383, no. 26, pp. 2547-2556, 2020.
, “Fetal loss and malformations in the MONEAD study of pregnant women with epilepsy.”, Neurology, vol. 94, no. 14, pp. e1502-e1511, 2020.
, “Changes in antiepileptic drug-prescribing patterns in pregnant women with epilepsy.”, Epilepsy Behav, vol. 84, pp. 10-14, 2018.
, “Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years.”, JAMA Pediatr, vol. 168, no. 8, pp. 729-36, 2014.
, “Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years.”, Epilepsy Behav, vol. 29, no. 2, pp. 308-15, 2013.
, “Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.”, Lancet Neurol, vol. 12, no. 3, pp. 244-52, 2013.
, “Fetal antiepileptic drug exposure: motor, adaptive, and emotional/behavioral functioning at age 3 years.”, Epilepsy Behav, vol. 22, no. 2, pp. 240-6, 2011.
, “Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age.”, Brain, vol. 134, no. Pt 2, pp. 396-404, 2011.
, “Relationship of child IQ to parental IQ and education in children with fetal antiepileptic drug exposure.”, Epilepsy Behav, vol. 21, no. 2, pp. 147-52, 2011.
, “Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs.”, N Engl J Med, vol. 360, no. 16, pp. 1597-605, 2009.
,